Stryker Corporation company logo

# RNN 2nd Gen Model Stryker Corporation Surgical & medical instruments

Prediction models:
Subscribe >> Deal exit on
June 22, 2018
Deal entry on
June 22, 2018
10.75%Expected margin
0.00% Successful deals
$ 172.00 Last close price
at 22-jun-2018

SYK

Model's trade recommendations No return for period yet

$62.42B Market Cap

β 0.70  

SYK

Model (following trade recommendations)

SYK

Underlying stock

S&P 500

Index
Return for period
-1.02%
1.78%
52wk return
21.88%
16.82%
52wk Range
138.22—179.78
2000.54—2399.63
Norm. RMSE 11.66%
  • 1.88 (1.13%) Div (Yield)
  • BUY Analysts consensus recommendation

Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Stryker Corporation (SYK) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 19, 2017.

Market data for SYK model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a regular basis.

Float 346M
P/E 24.97
Shares Outstanding 374M
% Held by Insiders 7.40%
% Held by Institutions 75.62%
EPS (last reported FY) $6.49
EPS (last reported Q) $1.68
EPS, estimated (last reported Q) $1.60
Total revenues $12 B
Net income $1 B